Claim Missing Document
Check
Articles

Found 4 Documents
Search
Journal : Prosiding University Research Colloquium

Respiratory Rehabilitation in COVID-19 Patients with Breathlessness: Literature Review Agung Cuby Hantoro; Siti Soekiswati
Prosiding University Research Colloquium Proceeding of The 15th University Research Colloquium 2022: Mahasiswa (Student Paper Presentation) A
Publisher : Konsorsium Lembaga Penelitian dan Pengabdian kepada Masyarakat Perguruan Tinggi Muhammadiyah 'Aisyiyah (PTMA) Koordinator Wilayah Jawa Tengah - DIY

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (224.688 KB)

Abstract

COVID-19 attacks the respiratory system caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). In Indonesia, as many as 32% of patients infected with SARS-CoV2 require ICU care. Patients are more likely to experience shortness of breath and death. Rehabilitation efforts in physical medicine specialists and medical rehabilitation are very important in improving respiratory function. The purpose of this study was to identify and analyze respiratory rehabilitation efforts in COVID-19 patients with shortness of breath. This research is a literature review type using the PRISMA method. Data were collected by browsing the Pubmed, Science Direct, and Google Scholar databases. The search results obtained 2,982 articles, then 11 articles were carried out with a literature review. In 11 articles analyzed, it was found that respiratory rehabilitation in COVID-19 patients can be carried out by administering oxygen therapy including (Nasal Canula (NC), endotracheal intubation, and tracheostomy). Breathing exercises include (pursed lip breathing, slow deep breathing, prone position, and regular breathing in a forward leaning position). Airway clearance techniques include (huffing, control cough, incentive spirometry, postural drainage, and sputum clearance) and passive exercises in bed. In conclusion, there is no better rehabilitation program. The rehabilitation program should be given as early as possible to achieve maximum stability in a shorter time.
Correlation of Age and Paracetamol Administration with AEFI Reactions Post Moderna Vaccination at Puskesmas Mojosongo Boyolali Syah Fillia Nurul Maslahah; Nining Lestari; Nida Faradisa Fauziyah; Siti Soekiswati
Prosiding University Research Colloquium Proceeding of The 15th University Research Colloquium 2022: Mahasiswa (Student Paper Presentation) A
Publisher : Konsorsium Lembaga Penelitian dan Pengabdian kepada Masyarakat Perguruan Tinggi Muhammadiyah 'Aisyiyah (PTMA) Koordinator Wilayah Jawa Tengah - DIY

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (152.859 KB)

Abstract

Many moderna vaccine recipients complain about the presence of AEFI (Adverse Events Following Immunization). Based on CDC data, the frequency of AEFI is higher in the 18-64 year age group. Some studies explain that minor AEFI reactions are managed with paracetamol and subside about 1-2 days after administration of the vaccine. This study aims to determine the relationship between age and administration of paracetamol with AEFI reactions after moderna vaccination at Puskesmas Mojosongo Boyolali. This study used an analytic observational survey research with a cross sectional research design which was carried out with quantitative methods. The data source used is primary data with a g-form questionnaire. This research was conducted at Puskesmas Mojosongo Boyolali, Central Java. The sampling technique in this study was non-random sampling with purposive sampling. The number of respondents is 72 people. The results of the logistic regression test of the relationship between age and AEFI reaction obtained the value of Exp(B) or OR=1.118 (p=0.883). Logistic regression test of the relationship between the administration of paracetamol with the AEFI reaction obtained the value of Exp (B) or OR = 1.949 (p = 0.452). The results of multivariate analysis showed that the variables of age and administration of paracetamol did not have a significant relationship with the reaction of AEFI after moderna vaccination.
Respiratory Rehabilitation in COVID-19 Patients with Breathlessness: Literature Review Hantoro, Agung Cuby; Soekiswati, Siti
Prosiding University Research Colloquium Proceeding of The 15th University Research Colloquium 2022: Mahasiswa (Student Paper Presentation) A
Publisher : Konsorsium Lembaga Penelitian dan Pengabdian kepada Masyarakat Perguruan Tinggi Muhammadiyah 'Aisyiyah (PTMA) Koordinator Wilayah Jawa Tengah - DIY

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

COVID-19 attacks the respiratory system caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). In Indonesia, as many as 32% of patients infected with SARS-CoV2 require ICU care. Patients are more likely to experience shortness of breath and death. Rehabilitation efforts in physical medicine specialists and medical rehabilitation are very important in improving respiratory function. The purpose of this study was to identify and analyze respiratory rehabilitation efforts in COVID-19 patients with shortness of breath. This research is a literature review type using the PRISMA method. Data were collected by browsing the Pubmed, Science Direct, and Google Scholar databases. The search results obtained 2,982 articles, then 11 articles were carried out with a literature review. In 11 articles analyzed, it was found that respiratory rehabilitation in COVID-19 patients can be carried out by administering oxygen therapy including (Nasal Canula (NC), endotracheal intubation, and tracheostomy). Breathing exercises include (pursed lip breathing, slow deep breathing, prone position, and regular breathing in a forward leaning position). Airway clearance techniques include (huffing, control cough, incentive spirometry, postural drainage, and sputum clearance) and passive exercises in bed. In conclusion, there is no better rehabilitation program. The rehabilitation program should be given as early as possible to achieve maximum stability in a shorter time.
Correlation of Age and Paracetamol Administration with AEFI Reactions Post Moderna Vaccination at Puskesmas Mojosongo Boyolali Maslahah, Syah Fillia Nurul; Lestari, Nining; Fauziyah, Nida Faradisa; Soekiswati, Siti
Prosiding University Research Colloquium Proceeding of The 15th University Research Colloquium 2022: Mahasiswa (Student Paper Presentation) A
Publisher : Konsorsium Lembaga Penelitian dan Pengabdian kepada Masyarakat Perguruan Tinggi Muhammadiyah 'Aisyiyah (PTMA) Koordinator Wilayah Jawa Tengah - DIY

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Many moderna vaccine recipients complain about the presence of AEFI (Adverse Events Following Immunization). Based on CDC data, the frequency of AEFI is higher in the 18-64 year age group. Some studies explain that minor AEFI reactions are managed with paracetamol and subside about 1-2 days after administration of the vaccine. This study aims to determine the relationship between age and administration of paracetamol with AEFI reactions after moderna vaccination at Puskesmas Mojosongo Boyolali. This study used an analytic observational survey research with a cross sectional research design which was carried out with quantitative methods. The data source used is primary data with a g-form questionnaire. This research was conducted at Puskesmas Mojosongo Boyolali, Central Java. The sampling technique in this study was non-random sampling with purposive sampling. The number of respondents is 72 people. The results of the logistic regression test of the relationship between age and AEFI reaction obtained the value of Exp(B) or OR=1.118 (p=0.883). Logistic regression test of the relationship between the administration of paracetamol with the AEFI reaction obtained the value of Exp (B) or OR = 1.949 (p = 0.452). The results of multivariate analysis showed that the variables of age and administration of paracetamol did not have a significant relationship with the reaction of AEFI after moderna vaccination.